| Clinically and pharmacologically relevant interactions of antidiabetic drugs M May, C Schindler Therapeutic advances in endocrinology and metabolism 7 (2), 69-83, 2016 | 195 | 2016 |
| Role of the vasodilator peptide angiotensin-(1–7) in cardiovascular drug therapy C Schindler, P Bramlage, W Kirch, CM Ferrario Vascular health and risk management 3 (1), 125, 2007 | 156 | 2007 |
| Improved insulin sensitivity with angiotensin receptor neprilysin inhibition in individuals with obesity and hypertension J Jordan, R Stinkens, T Jax, S Engeli, EE Blaak, M May, B Havekes, ... Clinical Pharmacology & Therapeutics 101 (2), 254-263, 2017 | 147 | 2017 |
| Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2: A phase 1 randomized clinical trial PG Kremsner, P Mann, A Kroidl, I Leroux-Roels, C Schindler, JJ Gabor, ... Wiener Klinische Wochenschrift 133 (17), 931-941, 2021 | 110 | 2021 |
| Prescriptions of systemic antibiotics for children in Germany aged between 0 and 6 years C Schindler, J Krappweis, I Morgenstern, W Kirch Pharmacoepidemiology and drug safety 12 (2), 113-120, 2003 | 109 | 2003 |
| Phase 1 assessment of the safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 in human volunteers P Kremsner, P Mann, J Bosch, R Fendel, JJ Gabor, A Kreidenweiss, ... MedRxiv, 2020.11. 09.20228551, 2020 | 95 | 2020 |
| Modern pharmacological treatment of obese patients M May, C Schindler, S Engeli Therapeutic advances in endocrinology and metabolism 11, 2042018819897527, 2020 | 92 | 2020 |
| The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? C Schindler Therapeutic Advances in Cardiovascular Disease 1 (1), 7-26, 2007 | 78 | 2007 |
| Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive … A Schneeweiss, TW Park-Simon, J Albanell, U Lassen, J Cortés, V Dieras, ... Investigational new drugs 36, 848-859, 2018 | 76 | 2018 |
| Effects of Ginkgo biloba extract EGb 761® on cognitive control functions, mental activity of the prefrontal cortex and stress reactivity in elderly adults with subjective … SM Beck, H Ruge, C Schindler, M Burkart, R Miller, C Kirschbaum, ... Human Psychopharmacology: Clinical and Experimental 31 (3), 227-242, 2016 | 56 | 2016 |
| Severe temporomandibular dysfunction and joint destruction after intra‐articular injection of triamcinolone C Schindler, L Paessler, U Eckelt, W Kirch Journal of oral pathology & medicine 34 (3), 184-186, 2005 | 55 | 2005 |
| Klinische Pathophysiologie B Amann-Vesti Georg Thieme Verlag, 2006 | 53 | 2006 |
| Pattern of prescriptions issued by nursing home‐based physicians versus office‐based physicians for frail elderly patients in German nursing homes D Pittrow, J Krappweis, A Rentsch, C Schindler, I Hach, P Bramlage, ... Pharmacoepidemiology and drug safety 12 (7), 595-599, 2003 | 52 | 2003 |
| Monoacylglycerol lipase inhibition in Tourette syndrome: a 12‐week, randomized, controlled study KR Müller‐Vahl, C Fremer, C Beals, J Ivkovic, H Loft, C Schindler Movement Disorders 36 (10), 2413-2418, 2021 | 44 | 2021 |
| Current pharmacotherapeutic concepts for the treatment of obesity in adults E Idelevich, W Kirch, C Schindler Therapeutic Advances in Cardiovascular Disease 3 (1), 75-90, 2009 | 44 | 2009 |
| Federated electronic health records research technology to support clinical trial protocol optimization: Evidence from EHR4CR and the InSite platform B Claerhout, D Kalra, C Mueller, G Singh, N Ammour, L Meloni, ... Journal of biomedical informatics 90, 103090, 2019 | 40 | 2019 |
| Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double‐blind crossover trial in healthy … C Schindler, KB Brosnihan, CM Ferrario, P Bramlage, U Maywald, R Koch, ... The Journal of Clinical Pharmacology 47 (1), 112-120, 2007 | 39 | 2007 |
| ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist`s perspective after publication of the results of ONTARGET C Schindler Therapeutic Advances in Cardiovascular Disease 2 (4), 233-248, 2008 | 35 | 2008 |
| First patient-centered drug information service in Germany—A descriptive study U Maywald, C Schindler, J Krappweis, W Kirch Annals of Pharmacotherapy 38 (12), 2154-2159, 2004 | 33 | 2004 |
| Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study A Tiede, C Hart, P Knöbl, R Greil, J Oldenburg, UJ Sachs, W Miesbach, ... The Lancet Haematology 10 (11), e913-e921, 2023 | 30 | 2023 |
